IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

FRANK CORONA

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1821197385
CMS profile
174164
Location
OCEANSIDE, CA

General Payments · PY2018–2024

$2,936.31

  • Reported across 156 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,190.94

51 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Pulmonary Disease CA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,111.00 50
Education $79.94 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
GlaxoSmithKline, LLC. $269.71 15
Regeneron Healthcare Solutions, Inc. $164.71 4
Boehringer Ingelheim Pharmaceuticals, Inc. $154.01 6
Actelion Pharmaceuticals US, Inc. $138.06 8
Takeda Pharmaceuticals U.S.A., Inc. $104.79 4
Philips Electronics North America Corporation $67.98 3
Acerta Pharma LLC $63.69 2
Insmed, Inc. $62.09 3
BAXTER HEALTHCARE $57.97 2
Grifols USA, LLC $54.13 2
Inspire Medical Systems, Inc. $27.59 1
Relypsa, Inc. $26.21 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $561.02 40
PY2019 $482.57 34
PY2020 $145.27 7
PY2021 $163.57 7
PY2022 $86.70 3
PY2023 $306.24 14
PY2024 $1,190.94 51

Payment records · PY2024 (51)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Actelion Pharmaceuticals US, Inc. $10.81 03/07/2024 Food and Beverage Undisputed 01/23/2026 1078870772 CMS
Actelion Pharmaceuticals US, Inc. $22.49 03/11/2024 Food and Beverage Undisputed 01/23/2026 1078870798 CMS
Actelion Pharmaceuticals US, Inc. $4.53 05/30/2024 Food and Beverage Undisputed 01/23/2026 1078870790 CMS
Actelion Pharmaceuticals US, Inc. $28.35 06/26/2024 Food and Beverage Undisputed 01/23/2026 1078870810 CMS
Actelion Pharmaceuticals US, Inc. $29.69 07/25/2024 Food and Beverage Undisputed 01/23/2026 1078870764 CMS
Actelion Pharmaceuticals US, Inc. $10.45 08/29/2024 Food and Beverage Undisputed 01/23/2026 1078870834 CMS
Actelion Pharmaceuticals US, Inc. $19.99 11/20/2024 Food and Beverage Undisputed 01/23/2026 1078870826 CMS
Actelion Pharmaceuticals US, Inc. $11.75 12/03/2024 Food and Beverage Undisputed 01/23/2026 1078870794 CMS
AstraZeneca Pharmaceuticals LP $28.55 01/25/2024 Food and Beverage Undisputed 01/23/2026 1104343116 CMS
AstraZeneca Pharmaceuticals LP $35.14 08/22/2024 Food and Beverage Undisputed 01/23/2026 1105501224 CMS
Baxter Healthcare $21.35 03/20/2024 Food and Beverage Undisputed 01/23/2026 1118295374 CMS
Baxter Healthcare $36.62 07/09/2024 Food and Beverage Undisputed 01/23/2026 1118295376 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.24 01/11/2024 Food and Beverage Undisputed 01/23/2026 1118168248 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $26.73 04/11/2024 Food and Beverage Undisputed 01/23/2026 1118168252 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $19.92 07/10/2024 Food and Beverage Undisputed 01/23/2026 1118168258 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $25.72 08/21/2024 Food and Beverage Undisputed 01/23/2026 1118168250 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $29.56 10/08/2024 Food and Beverage Undisputed 01/23/2026 1118168254 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $30.84 11/12/2024 Food and Beverage Undisputed 01/23/2026 1118168256 CMS
GlaxoSmithKline, LLC. $28.58 02/22/2024 Food and Beverage Undisputed 01/23/2026 1116667137 CMS
GlaxoSmithKline, LLC. $23.92 03/15/2024 Food and Beverage Undisputed 01/23/2026 1116403235 CMS
GlaxoSmithKline, LLC. $9.63 04/04/2024 Food and Beverage Undisputed 01/23/2026 1116499129 CMS
GlaxoSmithKline, LLC. $11.03 04/24/2024 Food and Beverage Undisputed 01/23/2026 1116414139 CMS
GlaxoSmithKline, LLC. $3.00 04/25/2024 Food and Beverage Undisputed 01/23/2026 1115769561 CMS
GlaxoSmithKline, LLC. $29.77 04/25/2024 Food and Beverage Undisputed 01/23/2026 1116557177 CMS
GlaxoSmithKline, LLC. $28.80 05/02/2024 Food and Beverage Undisputed 01/23/2026 1116439899 CMS
GlaxoSmithKline, LLC. $24.90 08/14/2024 Food and Beverage Undisputed 01/23/2026 1116564796 CMS
GlaxoSmithKline, LLC. $24.36 09/25/2024 Food and Beverage Undisputed 01/23/2026 1116624235 CMS
GlaxoSmithKline, LLC. $25.11 10/05/2024 Food and Beverage Undisputed 01/23/2026 1116612722 CMS
GlaxoSmithKline, LLC. $6.98 10/09/2024 Food and Beverage Undisputed 01/23/2026 1116283693 CMS
GlaxoSmithKline, LLC. $8.13 10/24/2024 Food and Beverage Undisputed 01/23/2026 1116412705 CMS
GlaxoSmithKline, LLC. $10.49 10/29/2024 Food and Beverage Undisputed 01/23/2026 1116177951 CMS
GlaxoSmithKline, LLC. $12.35 11/14/2024 Food and Beverage Undisputed 01/23/2026 1116437363 CMS
GlaxoSmithKline, LLC. $22.66 12/11/2024 Food and Beverage Undisputed 01/23/2026 1116537600 CMS
Grifols USA, LLC $27.17 03/29/2024 Food and Beverage Undisputed 01/23/2026 1124715191 CMS
Grifols USA, LLC $26.96 08/21/2024 Food and Beverage Undisputed 01/23/2026 1124715189 CMS
Insmed, Inc. $26.77 09/24/2024 Food and Beverage Undisputed 01/23/2026 1089579982 CMS
Insmed, Inc. $18.29 11/12/2024 Food and Beverage Undisputed 01/23/2026 1089569273 CMS
Insmed, Inc. $17.03 12/03/2024 Food and Beverage Undisputed 01/23/2026 1089566795 CMS
Inspire Medical Systems, Inc. $27.59 11/26/2024 Food and Beverage Undisputed 01/23/2026 1148049048 CMS
Philips North America LLC $21.45 08/07/2024 Food and Beverage Undisputed 01/23/2026 1146847841 CMS
Philips North America LLC $21.95 09/12/2024 Food and Beverage Undisputed 01/23/2026 1146847843 CMS
Philips North America LLC $24.58 11/07/2024 Food and Beverage Undisputed 01/23/2026 1146847839 CMS
Regeneron Healthcare Solutions, Inc. $26.80 03/14/2024 Food and Beverage Undisputed 01/23/2026 1114029815 CMS
Regeneron Healthcare Solutions, Inc. $24.38 10/11/2024 Food and Beverage Undisputed 01/23/2026 1114029817 CMS
Regeneron Healthcare Solutions, Inc. $79.94 12/12/2024 Education Undisputed 01/23/2026 1114029819 CMS
Regeneron Healthcare Solutions, Inc. $33.59 12/13/2024 Food and Beverage Undisputed 01/23/2026 1114029821 CMS
Takeda Pharmaceuticals U.S.A., Inc. $27.07 04/24/2024 Food and Beverage Undisputed 01/23/2026 1137519301 CMS
Takeda Pharmaceuticals U.S.A., Inc. $21.27 06/28/2024 Food and Beverage Undisputed 01/23/2026 1137519305 CMS
Takeda Pharmaceuticals U.S.A., Inc. $34.40 10/09/2024 Food and Beverage Undisputed 01/23/2026 1137519308 CMS
Takeda Pharmaceuticals U.S.A., Inc. $22.05 12/17/2024 Food and Beverage Undisputed 01/23/2026 1137519312 CMS
Vifor Pharma, Inc. $26.21 09/26/2024 Food and Beverage Undisputed 01/23/2026 1124065076 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.